Agha Alinejad H., Molanouri Shamsi M. (2010) Exercise induced release of cytokines from skeletal muscle: Emphasis on IL-6. Iranian Journal of Endocrinology and Metabolism 12, 181-190. |
Bruunsgaard H., Galbo H., Halkjaer-Kristensen J., Johansen T.L., Maclean D.A., Pedersen B.K. (1997) Exercise-induced increase in serum inferleukin-6 in humans is related to muscle damage. Journal of Physiology 499, 833-841. |
Brzycki M. (1993) Strength testing. Predicting a one-rep max from reps-to-fatigue. Journal of Physical Education, Recreation & Dance 64, 88-90. |
Ciliberti E., Carambia L., Cavallin S., Cerda O.L., Poderoso J.J., Rabinovich G.A. (2009) Tolerance and autoimmunity. Novel therapeutic approaches. Conceptos emergentes de tolerancia y autoinmunidad: Nuevos enfoques terapeuticos 69, 460-465. |
Cordova A., Alvarez-Mon M. (1999a) Immune system (I): General concepts, adaptation to physical exercise and clinical implications (El sistema inmune (I): Conceptos generales, adaptacion al ejercicio fisico e implicaciones clínicas). Archivos de Medicina del Deporte 69, 47-54. |
Cordova A., Alvarez-Mon M. (1999b) Immune system (II): Effect of immunomodulators in recovery of sportsmen (El sistema inmune (II): Importancia de los inmunomoduladores en la recuperacion del deportista). Archivos de Medicina del Deporte 70, 155-165. |
Córdova A., Sureda A., Tur J.A., Pons A. (2010) Immune response to exercise in elite sportsmen during the competitive season. Journal of Physiology and Biochemistry 66, 1-6. |
Cordova Martinez A., Monserrat J., Villa G., Reyes E., Soto M.A.M. (2006) Effects of AM3 (Inmunoferon®) on increased serum concentrations of interleukin-6 and tumour necrosis factor receptors I and II in cyclists. Journal of Sports Sciences 24, 565-573. |
Croft L., Bartlett J.D., Maclaren D.P.M., Reilly T., Evans L., Mattey D.L., Nixon N.B., Drust B., Morton J.P. (2009) High-intensity interval training attenuates the exercise-induced increase in plasma IL-6 in response to acute exercise. Applied Physiology, Nutrition and Metabolism 34, 1098-1107. |
Dam B.V., Pruimboom L. (1992) Un nuevo test en tenis. Revista de Entrenamiento Deportivo 6, 29-33. |
Drenth J.P.H., Krebbers R.J.M., Bijzet J., Van Der Meer J.W.M. (1998) Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-beta production but decreased tumour necrosis factor-alpha production after a 5-km run. European Journal of Clinical Investigation 28, 866-872. |
Drenth J.P.H., Van Uum S.H.M., Van Deuren M., Pesman G.J., Van Der Ven- Jongekrijg J., Van Der Meer J.W.M. (1995) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1beta production. Journal of Applied Physiology 79, 1497-1503. |
Emmanuel G., Lie T. (1996) Increased plasma levels of Interleukin-1 receptor antagonist (IL-1ra) following short maximal exercise. Chest 110, 63S-. |
Gokhale R., Chandrashekara S., Vasanthakumar K.C. (2007) Cytokine response to strenuous exercise in athletes and non-athletes-an adaptive response. Cytokine 40, 123-127. |
Gray S.R., Robinson M., Nimmo M.A. (2008) Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men. Cell Stress and Chaperones 13, 247-251. |
Gridling M., Stark N., Madlener S., Lackber A., Popescu R., Benedek B., Diaz R., Tut F.M., Nha Vo T.P., Huber D., Gollinger M., Saiko P., Azmen A., Mosgoeller W., De Martin R., Eytner R., Wagner K.H., Grusch M., Fritzer-Szekeres M., Szekeres T., Kopp B., Frisch R., Krupitza G. (2009) In vitro anti-cancer activity of two ethno-pharmacological healing plants from Guatemala Pluchea odorata and Phlebodium decumanum. International Journal of Oncology 34, 1117-1128. |
Hasson S.M., Daniels J.C., Divine J.G., Niebuhr B.R., Richmond S., Stein P.G., Williams J.H. (1993) Effect of ibuprofen use on muscle soreness, damage, and performance: A preliminary investigation. Medicine and Science in Sports and Exercise 25, 9-17. |
Klentrou P., Cieslak T., Macneil M., Vintinner A., Plyley M. (2002) Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans. European Journal of Applied Physiology 87, 153-158. |
Moldoveanu A.I., Shephard R.J., Shek P.N. (2000) Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells. Journal of Applied Physiology 89, 1499-1504. |
Moldoveanu A.I., Shephard R.J., Shek P.N. (2001) The cytokine response to physical activity and training. Sports Medicine 31, 115-144. |
Nielsen A.R., Pedersen B.K. (2007) The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Applied Physiology, Nutrition and Metabolism 32, 833-839. |
Nieman D.C. (1997) Immune response to heavy exertion. Journal of Applied Physiology 82, 1385-1394. |
Nieman D.C., Henson D.A., Davis J.M., Dumke C.L., Utter A.C., Murphy E.A., Pearce S., Gojanovich G., Mcanulty S.R., Mcanulty L.S. (2006) Blood leukocyte mRNA expression for IL-10, IL-1Ra, and IL-8, but not IL-6, increases after exercise. Journal of Interferon and Cytokine Research 26, 668-674. |
Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. (1999) Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. Journal of Physiology 515, 287-291. |
Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. (2001) Chemokines are elevated in plasma after strenuous exercise in humans. European Journal of Applied Physiology 84, 244-245. |
Ostrowski K., Rohde T., Zacho M., Asp S., Pedersen B.K. (1998) Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. Journal of Physiology 508, 949-953. |
Pedersen B.K., Steensberg A., Fischer C., Keller C., Keller P., Plomgaard P., Febbraio M., Saltin B. (2003) Searching for the exercise factor: Is IL-6 a candidate?. Journal of Muscle Research and Cell Motility 24, 113-119. |
Pedersen B.K., Steensberg A., Fischer C., Keller C., Keller P., Plomgaard P., Wolsk-Petersen E., Febbraio M. (2004) The metabolic role of IL-6 produced during exercise: Is IL-6 an exercise factor?. Proceedings of the Nutrition Society 63, 263-267. |
Pedersen B.K., Toft A.D. (2000) Effects of exercise on lymphocytes and cytokines. British Journal of Sports Medicine 34, 246-51. |
Petersen A.M.W., Pedersen B.K. (2005) The anti-inflammatory effect of exercise. Journal of Applied Physiology 98, 1154-1162. |
Petersen A.M.W., Pedersen B.K. (2006) The role of IL-6 in mediating the anti-inflammatory effects of exercise. Journal of Physiology and Pharmacology 57, 43-51. |
Ploeger H.E., Takken T., De Greef M.H., Timmons B.W. (2009) The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exercise Immunology Review 15, 6-41. |
Punzón C., Alcaide A., Fresno M. (2003) In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors. International Immunopharmacology 3, 1293-1299. |
Ronsen O., Lea T., Bahr R., Pedersen B.K. (2002) Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes. Journal of Applied Physiology 92, 2547-2553. |
Ruth J.H., Bienkowski M., Warmington K.S., Lincoln P.M., Kunkel S.L., Chensue S.W. (1996) IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation. Journal of Immunology 156, 2503-2509. |
Sigal L., Ron Y. (1994) . Immunology and inflammation. Basic mechanisms and clinical consequences , -. |
Steensberg A. (2003) The role of IL-6 in exercise-induced immune changes and metabolism. Exercise Immunology Review 9, 40-47. |
Suzuki K., Nakaji S., Yamada M., Totsuka M., Sato K., Sugawara K. (2002) Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exercise Immunology Review 8, 6-48. |
Suzuki K., Yamada M., Kurakake S., Okamura N., Yamaya K., Liu Q., Kudoh S., Kowatari K., Nakaji S., Sugawara K. (2000) Circulating sytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. European Journal of Applied Physiology 81, 281-287. |
Tilg H., Dinarello C.A., Mier J.W. (1997) IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunology Today 18, 428-432. |
Tuominen M., Bohlin L., Rolfsen W. (1991) Anti-inflammatory and immunomodulatory activity of the fern Polypodium decumanum. Planta Medica 58, 306-310. |
Vasänge M., Rolfsen W., Bohlin L. (1997) A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. Journal of Pharmacy and Pharmacology 49, 562-566. |
Vasänge M., Tuominen M., Perera-Ivarsson P., Shen J., Bohlin L., Rolfsen W. (1994) The fern Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as inhibitors of leukotriene B4 formation. Prostaglandins Leukotrienes and Essential Fatty Acids 50, 279-284. |
Villarrubia V.G., Moreno Koch M.C., Calvo C., González S., Alvarez-Mon M. (1997) The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3. Immunopharmacology and Immunotoxicology 19, 53-74. |
|